Glossary

The main result measured to determine the effect of an intervention in a study.

The process by which a drug receives regulatory authorization for public use.

An individual who voluntarily takes part in a clinical study.

The lead researcher responsible for the overall conduct of a clinical trial.

An unintended reaction or consequence of a treatment or drug.

An adverse event that results in death, hospitalization, or significant disability.

The comparison of potential risks and benefits to participants in a clinical trial.

Side effects that prevent a dose from being increased further during trials.

The group of individuals participating in a clinical trial.

A process in early-phase trials where the dose of a drug is gradually increased to determine the optimal level.

The initial evaluation to determine if a person qualifies for participation in a clinical trial.

The researcher conducting and overseeing the clinical trial at a specific site.

The process of identifying and enrolling participants in a clinical trial.

A phenomenon where a participant experiences a perceived improvement in symptoms due to their belief in the treatment.